FDA Investigator Joanne M Schlossin
Joanne M Schlossin has inspections in 14 countries as of 12 Apr 2024. Joanne M Schlossin has collaborated with a combined 3864 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
214
Last Inspection Date:
12 Apr 2024
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Netherlands,
India,
Czechia,
China,
Italy,
Germany,
Switzerland,
France,
Romania,
United Kingdom of Great Britain and Northern Ireland,
Canada,
Australia,
El Salvador
Co-Investigator(s):
Ademola O Daramola,
Akbar J Zaidi,
Althea A Williams,
Alyssa R Favro,
Amanda E Lewin, PhD,
Andrea A Branche,
Andrew B Paglia, DPM,
Andrew M Abramowitz,
Anh M Lac,
Anissa M Vargas,
Ann B Okon,
Anthony A Charity,
Anthony J Grace,
Arduino Frankovic,
Arnold Seo, PhD,
Arthur G Hurst,
Audrey J Yarbrough,
Azza Talaat,
Barbara J Rincon,
Benton M Ketron,
Betsy C Galliher,
Bonnie L Fry,
Bonnie L Menzel,
Brandy N Lepage,
Bruce G Cooper,
Byungja E Marciante,
Camille D Brown,
Carmen Y Fisher,
Charles D Brown,
Charles R Bonapace, PhD,
Cheron M Portee,
Chilton,
Chmura,
Christopher D Rush,
Christopher J Smith,
Christopher S Fields,
Clinton V Giustra,
Crystal A Branch,
Cynthia A Harris, MD, RN,
Daniel J Lahar,
Daniel L Aisen,
David A Carlson,
David M Beltran,
David M Mcnew,
Dawn C Olenjack,
Denise L Burosh,
Diamond M Oden,
Diane E Bruce,
Dipesh K Shah,
Donald J Ullstrom,
Dr. Abhijit Raha, PhD,
Dr. Gopa Biswas, PhD,
Dr. Mark J Seaton, PhD,
Dr. Sriram Subramaniam, PhD,
Dr. Zhou Chen (nmi), MD PhD,
Dustin P Tran,
Elisa M Fleming,
Elizabeth D Connell,
Elizabeth H Davis,
Elizabeth H Slazak,
Erin L Nagel,
Farhana Khan,
Felix Maldonado,
Gabriel Davila,
Gajendiran Mahadevan, PhD,
Gary T Greco,
Gene R Gunn,
George C Amedro,
Gulshan R Anand,
Habacuc V Barrera,
Hamet Toure, PharmD MPH,
Harry J Brewer,
Hilary K Wagner,
Hugh M Mcclure, II,
Ingrid A Zambrana,
Iram R Hassan, PhD,
Irina Gaberman,
Iris C Macinnes,
Jackson Y See,
James D Bridges,
James M Kewley,
Jane Chen,
Janete F Guardia,
Jay T Wong,
Jeanette L Mcginnis,
Joel D Martinez,
Joel R Merriman,
Jogy George,
John A Gonzalez,
John A Podsadowski,
Jonathan D Green,
Joseph A Famiglietti,
Joseph J Vannelli,
Joshua C Schafer,
Joshua D Lopez,
Joy P Matthias,
Joyce A Williams,
Judy Keihl,
Julie Scoma,
Karen L Kosar,
Kathryn A Nagy,
Kathryn Suttling,
Kelly N Kerr,
Kenneth G Klobus,
Kent C Faul,
Kerun Hardeo,
Kham Phommachanh,
Kim M Downing,
Kimberley A Ricketts,
Kimberly Y Smithson,
Kyle J Spencer,
Ladislav Kermet,
Lance M De Souza, MBA,
Lata C Mathew, PhD,
Latorie S Jones,
Laura E Garcia,
Lauren E Blaser,
LCDR Chad N Thompson,
Leon L Crawley,
Li Hongpaul Yeh, PhD,
Linda Galindo,
Linda M Moore,
Linda M Sacco,
Lisa A Doyle,
Lourdes Andujar,
Madushini Dharmasena, PhD,
Makini Cobourne Duval, PhD,
Marc S Neubauer,
Margaret E Sarles,
Margaret M Annes,
Marijo B Kambere, PhD,
Marilyn S Babu,
Marlene L Davis,
Martinez,
Mary Alice B Garlipp,
Mary M Finn,
Matthew C Watson,
Matthew D Schnittker,
Melissa N Gregorio,
Melkamu Getie Kebtie, PhD,
Michael A Charles,
Michael F Skelly, PhD,
Michael G Sinkevich,
Michael R Dominick,
Michael W Burd,
Michelle J Hines,
Michelle M Noe Varga,
Mindy M Chou,
Mohsen Rajabi Abhari, FDA,
Morris Paul,
Mra Davism,
Mra Narulaa,
Muralidhara B Gavini, PhD,
Nancy A Bellamy,
Nancy G Schmidt,
Nancy M Espinal,
Nicholas C Mendiola,
Nicholas L Paulin,
Omadevi Somai, Investigator,
Pamela L Vega,
Pankaj H Amin,
Parul M Patel,
Patricia H Dlugosz,
Paul A Bonneau,
Paul Mouris,
Pauline N Logan,
Peter M Trunk,
Philip M Steele, PhD,
Phillip Angart, PhD,
Phillip D Waldron,
Randi Lynn Bodoh,
Richard K Glabach,
Richard W Berning,
Robert C Steyert,
Robert J Veitch,
Robin R Waller,
Robles,
Ruben C Ayala, PharmD,
Russ E Davis,
Ruth E Medcalf,
Sabine Francke,
Sajin Bae,
Samantha J Pinizzotto, D V M,
Sasha M Latonis,
Scott B Laufenberg,
Scott T Ballard,
Shannon A Dinardo,
Simone E Pitts,
Smith,
Sony Mathews,
Sripal R Mada, PhD,
Stacey F Rivette,
State Agency,
Stefanie R Cook,
Stephen L Beekman,
Steven E Bowen, PhD,
Steven J Libal,
Stuart W Russell,
Syeda N Mahazabin,
Tammy S Notto,
Tara K Carmody,
Tara K Normandin,
Terrance L Thomas,
Terri E Gibson,
Theressa B Smith,
Thomas L Bellonte,
Thomas P Hansen,
Thomas W Gordon,
Travis M Beard,
Tricia S Martinez,
Tyanna N Hadley,
Vickie J Kanion,
Wendy M Stone,
William P Chilton,
Xiaohan Cai, PhD,
Xikui Chen (nmi), PhD,
Yiyue Zhang (nmi), PhD
Joanne M Schlossin's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more